title: Phrenic nerve compound muscle action potential amplitude: biomarker of disease progression in ALS?
authors.affiliation: Department of Neurology, Westmead Hospital, Western Clinical School, University of Sydney, P.O. Box 533, Wentworthville, NSW, 2145 Sydney, Australia. Tel.: +61 2 9845 6097; fax: +61 2 9635 6684.. Electronic address: s.vucic@powmri.edu.au.
authors.forename: Steve
authors.initials: S
authors.lastname: Vucic
mesh_terms: D000200:Action Potentials / Q000502:physiology*; D000690:Amyotrophic Lateral Sclerosis / Q000175:diagnosis / Q000503:physiopathology*; D015415:Biomarkers; D006801:Humans; D010791:Phrenic Nerve / Q000502:physiology*; D012129:Respiratory Function Tests / Q000379:methods; D012132:Respiratory Muscles / Q000294:innervation / Q000502:physiology*
chemical_list: D015415:Biomarkers